Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

Periodontitis, a common form of gum disease, has long been linked to cardiovascular issues. Meta-analyses suggest a 30% ...

Research has shown that people with chronic kidney disease (CKD) are much more likely to develop heart disease. One large ...

The American Heart Association and the American College of Cardiology have issued its first set of guidelines to help reduce ...

While certain health metrics such as your resting heart rate or cholesterol levels may change over time, age alone doesn’t ...

Saving Benefits of Lifting Weights This systematic review and meta-analysis provides the strongest evidence to date that resistance training is associa ...

Your personality might be shaping your stress, health, and success in ways you’ve never considered. Have you ever caught ...

Sponsor:  American Heart AssociationDowntown Columbus will turn into a sea of red as the American Heart Association hosts ...

Some things we eat or drink raise our risk of deadly diseases like heart disease or cancer. But, strangely, a recent paper ...

New guidelines from the American Heart Association and American College of Cardiology recommend earlier treatment to address ...

The new approval allows the GLP-1 to be used to treat adults with the liver disease metabolic dysfunction-associated steatohepatitis (MASH) and liver scarring. Wegovy is the first GLP-1 to receive ...

New guidance issued by the American Heart Association and leading medical groups recommends new treatments for high blood ...